Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide and is associated with significant health care costs and burden. Management of HCC is guided based on the Barcelona Clinic Liver Cancer (BCLC) system and includes liver transplantation, surgical resection, and liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Zunirah, Lee, Sunyoung S, Victor, David W, Kodali, Sudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617526/
https://www.ncbi.nlm.nih.gov/pubmed/37915617
http://dx.doi.org/10.2147/JHC.S395080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617526/
https://www.ncbi.nlm.nih.gov/pubmed/37915617
http://dx.doi.org/10.2147/JHC.S395080

Ejemplares similares